Also, we confirmed that RBM5-AS1 could be upregulated by RUNX2 overexpression (Fig. 2H), and RUNX2 expression could be induced by hypoxia (Fig. 2I) in breast cancer cells. This evidence concerns the gene RUNX2 and breast cancer.